Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00276159 · OUTCOME

Number of Patients Who Received Steroids

Study of Immune Response Modifier in the Treatment of Hematologic Malignancies · Source last updated 2019-09-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to Week 12

What was measured

Number of patients who received steroids allowing successful continuation of therapy.

Analysis population: Includes patients receiving at least 12 doses of 852A study drug.

Groups in this outcome

852A Treatment

Patients receiving at least 12 doses of 852A.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
852A Treatment6

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
852A Treatment2Not reportedNot reportedNot reportedNot reported
Complete source fields
anticipated Posting Date
2009-12
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      6
    units
    Participants
description
Number of patients who received steroids allowing successful continuation of therapy.
groups
  1. description
    Patients receiving at least 12 doses of 852A.
    id
    OG000
    title
    852A Treatment
param Type
NUMBER
population Description
Includes patients receiving at least 12 doses of 852A study drug.
reporting Status
POSTED
time Frame
Up to Week 12
title
Number of Patients Who Received Steroids
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice